Body Composition and Alzheimer’s Disease: A Holistic Review
-
Published:2024-09-04
Issue:17
Volume:25
Page:9573
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Frank Giulia12ORCID, Gualtieri Paola3ORCID, Cianci Rossella45ORCID, Caldarelli Mario45ORCID, Palma Roselisa12, De Santis Gemma Lou3, Porfilio Chiara2, Nicoletti Francesco3, Bigioni Giulia3, Di Renzo Laura3ORCID
Affiliation:
1. PhD School of Applied Medical-Surgical Sciences, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy 2. School of Specialization in Food Science, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy 3. Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy 4. Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy 5. Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy
Abstract
Alzheimer’s disease (AD) represents a significant global health challenge and affects approximately 50 million people worldwide. This overview of published reviews provides a comprehensive understanding of the intricate correlations between AD and body composition, focusing particularly on obesity. We used a systematic approach to collect and analyze relevant reviews on the topic of obesity and Alzheimer’s disease. A comprehensive search of electronic databases, including PubMed, MEDLINE, and Google Scholar, was conducted. We searched keywords such as “Alzheimer’s disease”, “body composition”, “lean mass”, “bone mass”, and “fat mass”. We considered only reviews written within the past 5 years and in English. Fifty-six relevant reviews were identified that shed light on the multiple connections between AD and body composition. The review involves several aspects, including the impact of lean mass, bone mass, and endocrinological factors related to obesity, as well as inflammation, neuroinflammation, and molecular/genetic factors. The findings highlight the complex interplay of these elements in the development of AD, underscoring the need for holistic approaches to reduce the risk of AD and to explore innovative strategies for diagnosis, prevention, and treatment.
Funder
Italian Ministry of Health
Reference92 articles.
1. Brayne, C., and Miller, B. (2017). Dementia and Aging Populations-A Global Priority for Contextualized Research and Health Policy. PLoS Med., 14. 2. Alzheimer’s Disease;Scheltens;Lancet,2021 3. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE Ε4, and Cognitive Impairment;Therriault;Neurology,2021 4. Maisam, M., Khan, M.T., Lodhi, M.S., Mou, K., Liu, Z., and Wei, D. (2023). Alzheimer’s Disease; Mechanism, Mutations, and Applications of Nano-Medicine. Front. Biosci., 28. 5. Wang, H., Sun, M., Li, W., Liu, X., Zhu, M., and Qin, H. (2023). Biomarkers Associated with the Pathogenesis of Alzheimer’s Disease. Front. Cell. Neurosci., 17.
|
|